Seattle Genetics (SGEN) Misses Q1 EPS by 6c
Tweet
Share
E-mailGet Alerts SGEN Hot Sheet
Price: $228.74 --0%
Financial Fact:
Revenue from collaboration and license agreements: 23.97M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Revenue from collaboration and license agreements: 23.97M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Seattle Genetics (NASDAQ: SGEN) reported Q1 EPS of ($0.15), $0.06 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $111.2 million versus the consensus estimate of $116.49 million.
For earnings history and earnings-related data on Seattle Genetics (SGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is Treasury selloff a major issue for stock market bulls?
- BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
- Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
